1. Amosov VI, Speranskaya AA. Radiation diagnosis of interstitial lung diseases. St. Petersburg: ELBI SPb. 2015: 176 p. (In Russian).

2. Interstitial and orthopedic lung diseases. Library specialist doctor. By ed. M. Milkovich. Moscow, Geotar. 2016; 560 p.

3. Leonova EI. Endothelial dysfunction in interstitial lung diseases. Practical Pulmonology. 2017;(3):66-72. (In Russian).

4. Makinodan K, Itoh T, Tomoda K. Acute pulmonary thromboembolism associated with interstitial pneumonia. Intern Med. 2008;47:647-50.

5. Pfitzner J, Pfitzner L. The theoretical basis for using apnoeic oxygenation via the non-ventilated lung during one-lung ventilation to delay the onset of arterial hypoxaemia. Anaesth Intensive Care. 2005;33(6):794-800.

6. McLaughlin V. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis. Rheumatology. 2009;48:25-31.

7. Tsareva N, Avdeev S, Naumenko Zh, Neklyudova G. Pulmonary hypertension. Moscow: Geotar-Media; 2015; 416 p. (In Russian).

8. Carbone RG, Montanaro F, Bottino G. Interstitial lung disease: introduction. In: Baughman RP, Carbone RG, Bottino G, eds. Pulmonary arterial hypertension and interstitial lung diseases: a clinical guide. New York: Humana Press; 2009: 3-12.

9. Ramirez A, Varga J. Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management. Treat Respir Med. 2004;3:339-52.

10. Patschersky FN. Pulmonary arterial hypertension: clinical picture, diagnosis, treatment. Irkutsk: ISMU; 2015; 94 p. (In Russian).

11. Zakynthinos E, Daniil Z, Papanikolaou G, Makris D. Curr Drug Targets. Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets 2011; Jan 3. [Epub ahead of print]PMID: 21194405

12. Hasegava B. SPECT and SPECT/CT. 92nd Scientific Assembly and Annual Meeting Radiologic Society of North America. 2006: 171 p.

13. Levite EM, Uglonsky AN. The role of bypass in the lungs in the development of respiratory failure. Vestnik KRSU. 2014;14(5):75-8. (In Russian).